Robert D. Ciappenelli serves as Executive at Dicerna Pharmaceuticals Inc, where they oversee executive responsibilities. Since joining the company, Robert D. Ciappenelli has executed 8 insider transactions totaling $1.1M, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 28, 2021 involved transacting 14,813 shares valued at $566.6K.
Robert D. Ciappenelli currently holds 16,054 shares of Dicerna Pharmaceuticals Inc (DRNA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert D. Ciappenelli has been a net seller of DRNA stock. They have purchased $0 and sold $1.1M worth of shares.
Robert D. Ciappenelli's most recent insider trade was on Dec 28, 2021, when they sold 14,813 shares at $38.25 per share.
Get notified when new Form 4 filings are submitted
| 3,425 |
| $N/A |
| Discretionary |
| Dec 15, 2021 | DRNA | $47.2K | Payment | 1,241 | $38.05 | Discretionary |
| Dec 13, 2021 | DRNA | $200.0K | Option Exercise | 8,856 | $22.58 | Discretionary |
| Jun 14, 2021 | DRNA | $312.2K | Option Exercise | 20,000 | $15.61 | Discretionary |
| Jun 14, 2021 | DRNA | $760.0K | Sale | 20,000 | $38.00 | Discretionary |
| Jun 11, 2021 | DRNA | $156.1K | Option Exercise | 10,000 | $15.61 | Discretionary |
| Jun 11, 2021 | DRNA | $350.0K | Sale | 10,000 | $35.00 | Discretionary |